Effect of antiepileptic drugs on the postictal state. A critical overview

Epilepsy and Behavior

Volumn 19, Issue 2, 2010, Pages 176-181

  Schmidt, Dieter ^a  

^a Epilepsy Research Group   (Germany)

Author keywords

Antiepileptic drugs; Epilepsy; Lamotrigine; Levetiracetam; Modern antiepileptic drugs; Postictal dysfunction; Postictal state; Topiramate; Valproate; Zonisamide

Indexed keywords

ANTICONVULSIVE AGENT; ESLICARBAZEPINE ACETATE; ETIRACETAM; HARKOSERIDE; LAMOTRIGINE; RUFINAMIDE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

CONSCIOUSNESS; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; LIVERPOOL SEIZURE SEVERITY SCALE; PATIENT ASSESSMENT; POSTICTAL STATE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REVIEW; SEIZURE; SEIZURE SEVERITY SCALE; TREATMENT OUTCOME;

ANTICONVULSANTS; BRAIN; ELECTROENCEPHALOGRAPHY; HUMANS; SEIZURES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77957373097     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.06.019     Document Type: Review

References (33)

1. Cramer J.A., Blum D., Reed M., Fanning K. The influence of comorbid depression on seizure severity. Epilepsia 2003, 44:1578-1584. for the Epilepsy Impact Project Group.
2. Kwan P., Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001, 357:216-222.
3. Kanner A.M., Trimble M., Schmitz B. Postictal affective episodes. Epilepsy Behav 2010, Epub ahead of print.
4. Fisher R.S., Schachter S.C. The postictal state: a neglected entity in the management of epilepsy. Epilepsy Behav 2000, 1:52-59.
5. Helmstaedter C., Elger C.E., Lendt M. Postictal courses of cognitive deficits in focal epilepsies. Epilepsia 1994, 35:1073-1078.
6. Löscher W., Köhling R. Functional, metabolic, and synaptic changes after seizures as potential targets for antiepileptic therapy. Epilepsy Behav 2010, Epub ahead of print.
7. Elger C.E., Schmidt D. Modern management of epilepsy: a practical approach. Epilepsy Behav 2008, 12:501-539.
8. Cramer J.A., French J. Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components. Epilepsia 2001, 42:119-129.
9. Cramer J.A., Baker G.A., Jacoby A. Development of a new seizure severity questionnaire: initial reliability and validity testing. Epilepsy Res 2002, 48:187-197.
10. Smith D.F., Baker G.A., Dewey M., Jacoby A., Chadwick D.W. Seizure frequency, patient-perceived seizure severity and the psychosocial consequences of intractable epilepsy. Epilepsy Res 1991, 9:231-241.
11. Baker G.A., Smith D.F., Dewey M., Morrow J., Crawford P.M., Chadwick D.W. The development of a seizure severity scale as an outcome measure in epilepsy. Epilepsy Res 1991, 8:245-251.
12. Baker G.A., Smith D.F., Jacoby A., Hayes J.A., Chadwick D.W. Liverpool Seizure Severity Scale revisited. Seizure 1998, 7:201-205.
13. Scott-Lennox J., Bryant-Comstock L., Lennox R., Baker G.A. Reliability, validity and responsiveness of a revised scoring system for the Liverpool Seizure Severity Scale. Epilepsia Res 2001, 44:53-63.
14. Bautista R.E., Glen E.T. Seizure severity is associated with quality of life independent of seizure frequency. Epilepsy Behav 2009, 16:325-329.
15. O'Donoghue M.F., Duncan J.S., Sander J.W. The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Scale. Epilepsia 1996, 37:563-571.
16. Duncan J.S., Sander J.W. The Chalfont Seizure Severity Scale. J Neurol Neurosurg Psychiatry 1991, 54:873-876.
17. Vickrey B.G., Berg A.T., Sperling M.R., et al. Relationships between seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia 2000, 41:760-764.
18. Carpay J.A., Vermuelen J., Stroink T.H., et al. Seizure severity in children with epilepsy: a parent-completed scale compared with clinical data. Epilepsia 1997, 38:346-352.
19. Dodson W.E. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open label-study following a randomized clinical trial. Epilepsia 1993, 234(Suppl.7):S18-S24.
20. Sachdeo R.C., Glauser T.A., Ritter F., Reife R., Lim P., Pledger G. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999, 52:1182-1187.
21. Glauser T., Kluger G., Sachdeo R., Krauss G., Perdomo C., Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008, 70:1950-1958.
22. Speechley K.N., Sang X., Levin S., et al. Assessing severity of epilepsy in children: preliminary evidence of validity and reliability of a single-item scale. Epilepsy Behav 2008, 13:337-342.
23. Wagner L.J., Smith G.M., Ferguson P.L., Wannamaker B.B. Caregiver perceptions of seizure severity in pediatric epilepsy. Epilepsia 2009, 50:2102-2109.
24. Petersen B., Walker M.L., Uwe Runge U., Kessler C. Quality of life in patients with idiopathic, generalized epilepsy. J Epilepsy 1998, 11:306-313.
25. Bryant-Comstock L., Scott-Lennox J., Lennox R. Assessment of seizure severity with adjunctive lamotrigine therapy: results from a U.S. observational study. Epilepsy Behav 2001, 2:152-157.
26. Smith D., Baker G., Davies, Dewey T.M., Chadwick D.W. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993, 34:312-322.
27. French J. Proof of efficacy trials: endpoints. Epilepsy Res 2001, 45:53-56.
28. Tilz C., Stefan H., Hopfengaertner R., Kerling F., Genow A., Wang-Tilz Y. Influence of levetiracetam on ictal and postictal EEG in patients with partial seizures. Eur J Neurol 2006, 13:1352-1358.
29. Kerr M.P., Baker G.A., Brodie M.J. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Epilepsy Behav 2005, 7:472-480.
30. Dupont S., Striano S., Trinka E., et al. Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open label study (ZEUS). Acta Neurol Scand 2010, 121:141-148.
31. Halász P., Kälviäinen R., Mazurkiewicz-Beldzińska M., et al. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 2009, 50:443-453.
32. Chung S., Sperling M., Biton V., Krauss G., Beaman M., Hebert D. Lacosamide: efficacy and safety as oral adjunctive treatment for partial-onset seizures. Epilepsia 2007, 48(Suppl. 6):321.
33. De la Loge C., Cramer J., Borghs S., Mueller K., Eggert-Formella A., Doty P. Improvement in patient reported outcomes in patients responding to lacosamide: pooled QOLIE-31, SSQ and PGIC data from three phase II/III clinical trials. Poster presented at the UCB exposition during the American Epilepsy Society Meeting 2009.